Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Coloplast As ADR (CLPBY)

Coloplast As ADR (CLPBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Coloplast As ADR HOLTEDAM 1-3 HUMLEBAEK G7 3050 DNK

www.coloplast.com P: 45-4911-1111

Description:

Coloplast A/S engages in the development and sale of intimate healthcare products and services principally in Denmark, the United States, the United Kingdom, France and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology and Advanced Wound Care segments. Coloplast A/S is based in Humleb'k, Denmark.

Key Statistics

Overview:

Market Capitalization, $K 26,805,600
Enterprise Value, $K 29,027,440
Shares Outstanding, K 2,160,000
Annual Sales, $ 3,513 M
Annual Net Income, $ 685,880 K
Last Quarter Sales, $ 953,910 K
Last Quarter Net Income, $ 175,010 K
EBIT, $ 990,110 K
EBITDA, $ 1,143 M
60-Month Beta 0.09
% of Institutional Shareholders 0.00%
Float, K 0
% Float 0.00%
Short Volume Ratio 0.18

Growth:

1-Year Return -15.00%
3-Year Return -24.10%
5-Year Return 0.00%
5-Year Revenue Growth 33.66%
5-Year Earnings Growth 13.79%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings 0.08 on 02/09/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm 0.33
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 14.29%
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 05/11/20
Dividend Payable Date 05/28/20
Dividend Payout Ratio 0.00%

CLPBY Ratios

Ratio
Price/Earnings ttm 36.52
Price/Earnings forward 34.89
Price/Earnings to Growth 2.87
Return-on-Equity % 43.30%
Return-on-Assets % 11.89%
Profit Margin % 19.52%
Debt/Equity 1.08
Price/Sales 7.39
Price/Cash Flow 28.44
Price/Book N/A
Book Value/Share 0.00
Interest Coverage 7.43

CLPBY Dividends

Date Value
12/06/19 $0.1100
05/06/19 $0.0400
12/06/18 $0.1020
05/07/18 $0.0510
12/08/17 $0.0880
05/11/17 $0.0350
12/05/16 $0.0740
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar